Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

Human Gene Therapy

Volumn 11, Issue 2, 2000, Pages 263-270

  Laitinen, Marja ^a,b   Hartikainen, Juha ^b   Hiltunen, Mikko O ^a   Eränen, Jaakko ^b   Kiviniemi, Mikko ^a,b   Närvänen, Outi ^a   Mäkinen, Kimmo ^b   Manninen, Hannu ^b   Syvänne, Mikko ^c   Martin, John F ^d   Laakso, Markku ^b   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VASCULOTROPIN;

ADULT; AGED; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; FEMALE; GENE TRANSFER; HUMAN; MALE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIES; CATHETERIZATION; CORONARY VESSELS; DOUBLE-BLIND METHOD; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; LYMPHOKINES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034688216     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016003     Document Type: Article

References (30)

1. ALON, T., HEMO, I., IITIN, A., PE'ER, J., STONE, J., and KESHET, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024-1028.
2. ASAHARA, T., BAUTERS, C., PASTORE, C., KEARNAY, M., ROSSOW, S., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1995). Local delivery of vascular endothelial growth factor accelerates reendothelization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91, 2793-2801.
3. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia. Circulation 97, 1114-1123.
4. BITTL, J. A. (1996). Advances in coronary angioplasty. N. Engl. J. Med. 335, 1290-1302.
5. BREIER, G., ALBRECHT, U., STERRER, S., and RISAU, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
6. CALLOW, A.D., CHOI, E.T., TRACHTENBERG, J.D., STEVENS, S.L., CONNOLLY, D.T., RODI, C., and RYAN, U.S. (1994). Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty. Growth Factors 10, 223-228.
7. CAMENZIND, E., KINT, P.-P., DIMARIO, C., LIGHTHART, J., VAN DER GIESSEN, W., BOERSMA, E., and SERRUYS, P.W. (1995). Intracoronary heparin delivery in humans. Circulation 92, 2363-2372.
8. 165 in patient with ischemic limb. Lancet 348, 370-374.
9. KALNINS, A., RUTHER, O.K., and MULLER-HILL, B. (1983). Sequence of the lacZ gene of Escherichia coli. EMBO J. 2, 593-597.
10. KORNOWSKI, R., HONG, M.K., TIO, F.O., BRAMWELL, O., WU, H., and LEON, M.B. (1998). In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J. Am. Coll. Cardiol. 31, 224-230.
11. LAITINEN, M., ZACHARY, I., BREIER, G., PAKKANEN, T., HÄKKINEN, T., LUOMA, J., ABEDI, H., RISAU, W., SOMA, M., LAAKSO, M., MARTIN, J.F., and YLÄ-HERTTUALA, S. (1997a). VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum. Gene Ther. 8, 1737-1744.
12. LAITINEN, M., PAKKANEN, T., DONETTI, E., BAETTA, R., LUOMA, J., LEHTOLAINEN, P., VIITA, H., AGRAWAL, R., MIYANOHARA, A., FRIEDMANN, T., RISAU, W., MARTIN, J.F., SOMA, M., and YLÄ-HERTTUALA, S. (1997b). Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum. Gene Ther. 8, 1645-1650.
13. LAITINEN, M., MÄKINEN, K., MANNINEN, H., MATSI, P., KOSSILA, M., AGRAWAL, R., PAKKANEN, T., LUOMA, J.S., VIITA, H., HARTIKAINEN, J., ALHAVA, E., LAAKSO, M., and YLÄ-HERTTUALA, S. (1998). Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischaemia. Hum. Gene Ther. 9, 1481-1486.
14. LEUNG, D.W., CACHANES, G., KUANG, W.J., GOEDDEL, D.V., and FERRARA, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
15. LEW, D., PARKER, S.E., LATIMER, T., ABAI, A.M., KUWAHARA-RUNDELL, A., DOH, S.G., YANG, Z.-Y., LAFACE, D., GROMKOWSKI, S.H., NABEL, G.J., MANTHORPE, M., and NORMAN. J. (1995). Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6, 553-564.
16. LIBBY, P., SCHWARTZ, D., BROGI, E., TANAKA, H., and CLINTON, S.K. (1992). A cascade model for restenosis: A special case of atherosclerosis progression. Circulation 86, III-47-III-52.
17. LOSORDO, D.W., VALE, P.R., SYMES, J.F., DUNNINGTON, C.H., ESAKOF, D.D., MAYSKY, M., ASHARE, A.B., LATHI, K., and ISNER, J.M. (1998). Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.
18. NABEL, E.G., PLAUTZ, G., and NABEL, G.J. (1990). Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249, 1285-1288.
19. NARINS, C.R., HOLMES, D.R., JR., and TOPOL, E.J. (1998). A call for provisional stenting: The balloon is back! Circulation 97, 1298-1305.
20. PUUMALAINEN, A.-M., VAPALAHTI, M., AGRAWAL, R., KOSSILA, M., LAUKKANEN, J., LEHTOLAINEN, P., VIITA, H., PALJÄRVI, L., VANNINEN, R., and YLÄ-HERTTUALA, S. (1998). β-Galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum. Gene Ther. 9, 1769-1774.
21. REIBER, J.H.C., VAN DER ZWET, P.M.J., VON LAND, C.D., KONING, G., VAN MEURS, B., BUIS, B., and VAN VOORTHUISEN, A.E. (1993). In Advances in Quantitative Coronary Arteriography. J.H.C. Reiber and P.W. Serruys, eds. (Kluwer Academic Publishers, Dortrecht) pp. 75-111.
22. ROSENGART, T.K., LEE, L.Y., PATEL, S.R., SANBORN, T.A., PARIKH, M., BERGMAN, G.W., HACHAMOVITCH, R., SZULC, M., KLIGFIELD, P.D., OKIN, P.M., HAHN, R.T., DEVEREUX, R.B., POST, M.R., HACKETT, N.R., FOSTER, T., GRASSO, T.M., LESSER, M.L., ISOM, O.W., and CRYSTAL, R.G. (1999). Angiogenesis gene therapy. Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468-474.
23. SCHWARTZ, S.M., DE BLOIS, D., and O'BRIEN, E.R.M. (1995). The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77, 445-465.
24. SERRUYS, P.W., DE JAEGERE, P., KIEMENEIJ, F., MACAYA, C., RUTSCH, W., HEYNDRICKX, G., EMANUELSSON, H., MARCO, J., LEGRAND, V., and MATERNE, P. (1994). A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med. 331, 489-495.
25. SYVÄNNE, M., NIEMINEN, M.S., and FRICK, H. (1994). Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study. Int. J. Cardiac Imaging 10, 243-252.
26. TAKESHITA, S., TSURUMI, Y., COUFFINAHL, T., ASAHARA, T., BAUTERS, C., SYMES, J., FERRARA, N., and ISNER, J.M. (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487-501.
27. TURUNEN, M.P., HILTUNEN, M.O., RUPONEN, M., VIRKAMÄKI, L., SZOKA, F.C., JR., URTTI, A., and YLÄ-HERTTUALA, S. (1999). Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther. 6, 6-11.
28. VAN DER ZEE, R., MUROHARA, T., LUO, Z., ZOLLMANN, F., PASSERI, J., LEKUTATA, C., and ISNER, J.M. (1997). Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95, 1030-1037.
29. 2 in endothelial cells via p42/p44 mitogen activated protein kinase. FEBS Lett. 420, 28-32.
30. YLÄ-HERTTUALA, S., and MARTIN, J.F. (1999). Cardiovascular gene therapy. Lancet 354 (in press).